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ABSTRACT Nontypeable Haemophilus inﬂuenzae (NTHi) is an opportunistic pathogen
that mainly causes otitis media in children and community-acquired pneumonia or
exacerbations of chronic obstructive pulmonary disease in adults. A large variety of
studies suggest that bioﬁlm formation by NTHi may be an important step in the
pathogenesis of this bacterium. However, the underlying mechanisms involved in
this process are poorly elucidated. In this study, we used a transposon mutant li-
brary to identify bacterial genes involved in bioﬁlm formation. The growth and bio-
ﬁlm formation of 4,172 transposon mutants were determined, and the involvement
of the identiﬁed genes in bioﬁlm formation was validated in in vitro experiments.
Here, we present experimental data showing that increased bacterial lysis, through
interference with peptidoglycan synthesis, results in elevated levels of extracellular
DNA, which increased bioﬁlm formation. Interestingly, similar results were obtained
with subinhibitory concentrations of -lactam antibiotics, known to interfere with
peptidoglycan synthesis, but such an effect does not appear with other classes of
antibiotics. These results indicate that treatment with -lactam antibiotics, especially
for -lactam-resistant NTHi isolates, might increase resistance to antibiotics by in-
creasing bioﬁlm formation.
IMPORTANCE Most, if not all, bacteria form a bioﬁlm, a multicellular structure that
protects them from antimicrobial actions of the host immune system and affords re-
sistance to antibiotics. The latter is especially disturbing with the increase in multire-
sistant bacterial clones worldwide. Bacterial bioﬁlm formation is a multistep process
that starts with surface adhesion, after which attached bacteria divide and give rise
to biomass. The actual steps required for Haemophilus inﬂuenzae bioﬁlm formation
are largely not known. We show that interference with peptidoglycan biosynthesis
increases bioﬁlm formation because of the release of bacterial genomic DNA. Subin-
hibitory concentrations of -lactam antibiotics, which are often prescribed to treat
H. inﬂuenzae infections, increase bioﬁlm formation through a similar mechanism.
Therefore, when -lactam antibiotics do not reach their MIC in vivo, they might not
only drive selection for -lactam-resistant clones but also increase bioﬁlm formation
and resistance to other antimicrobial compounds.
KEYWORDS DNA, Haemophilus inﬂuenzae, bioﬁlms, otitis media, peptidoglycan,
postantibiotic effect
Received 29 October 2016 Accepted 31
December 2016 Published 18 January 2017
CitationMarti S, Puig C, Merlos A, Viñas M, de
Jonge MI, Liñares J, Ardanuy C, Langereis JD.
2017. Bacterial lysis through interference with
peptidoglycan synthesis increases bioﬁlm
formation by nontypeable Haemophilus
inﬂuenzae.mSphere 2:e00329-16. https://
doi.org/10.1128/mSphere.00329-16.
Editor Ana Cristina Gales, Escola Paulista de
Medicina/Universidade Federal de São Paulo
Copyright © 2017 Marti et al. This is an open-
access article distributed under the terms of
the Creative Commons Attribution 4.0
International license.
Address correspondence to Sara Marti,
smartinm@bellvitgehospital.cat, or Jeroen D.
Langereis, Jeroen.Langereis@radboudumc.nl.
Beta-lactam antibiotics augment
nontypeable Haemophilus inﬂuenzae bioﬁlm
formation through release of genomic DNA
RESEARCH ARTICLE
Host-Microbe Biology
crossm
January/February 2017 Volume 2 Issue 1 e00329-16 msphere.asm.org 1
 o
n
 M
ay 15, 2017 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
Haemophilus inﬂuenzae is a Gram-negative human-restricted bacterium that formspart of our oropharyngeal microbiota, where it resides without causing disease
symptoms (1). H. inﬂuenzae strains are categorized into six distinct serotypes (a through
f) based on the polysaccharide capsule. Unencapsulated or nontypeable H. inﬂuenzae
(NTHi) strains are also isolated from patients. NTHi is most frequently associated with
inﬂammatory diseases of the human mucosa, including otitis media (OM), sinusitis, and
exacerbations of chronic obstructive pulmonary disease (COPD) (2–4).
Many bacterial pathogens form bioﬁlms during infection of the human host. The
ability of NTHi to form bioﬁlms in vivo during disease was ﬁrst visualized on tympa-
nostomy tubes collected from children with OM (5). Since then, bioﬁlm growth of NTHi
has been observed in the middle ear mucosa of children with OM (6), as well as in
bronchoalveolar lavage ﬂuid from individuals with cystic ﬁbrosis (7) and bronchiectasis
(8). This growth state protects bacteria against efﬁcient killing by the immune system
(9, 10), as well as enhances resistance to antimicrobials (11, 12).
Many studies have attempted to establish a link between bioﬁlm formation by NTHi
and its ability to cause disease. For instance, we found that especially NTHi strains
collected from patients with OM have the ability to form bioﬁlms in vitro (13). This is
consistent with in vivo experiments, where bioﬁlms in the ears of chinchillas were
associated with bacterial persistence (14). Although there are indications that bioﬁlm
formation is related to pathogenesis, the molecular mechanisms underlying NTHi
bioﬁlm formation are still not completely understood (15). It has been shown that
bioﬁlms that are formed both in vitro and in vivo contain signiﬁcant amounts of DNA,
either bacterial or host derived (14, 16). It has been shown that the DNA-associated
protein DNABII plays a relevant role in stabilizing the DNA matrix within the NTHi
bioﬁlm and that antisera against DNABII rapidly disrupt bioﬁlms (17).
To identify novel bacterial genes that are associated with NTHi bioﬁlm formation in
vitro, we performed an unbiased genome-wide mutagenesis screening by using a
clinical NTHi isolate. We provide evidence that disruption of peptidoglycan synthesis
and recycling, either by making gene deletion mutants or by using subinhibitory
concentrations of -lactam antibiotics, increases sensitivity to bacterial lysis, releasing
bacterial DNA that contributes to bioﬁlm formation in vitro.
RESULTS
Transposon mutant library bioﬁlm screening. We generated transposon mutants
of NTHi strain 13/4, a bioﬁlm-forming isolate from an oropharyngeal swab collected
from a healthy child (18). This strain was selected because it formed a bioﬁlm in vitro,
it had low incorporation of phosphorylcholine into the lipooligosaccharide (19), and
transformation with mutagenized DNA obtained a sufﬁcient number of transposon
mutants.
We determined in vitro bioﬁlm formation and growth in two experiments with 1,806
and 2,366 colonies, and the data were combined for a total of 4,172 colonies. Eight
hundred ten transposon mutants (310 and 500 in the ﬁrst and second experiments,
respectively) showed normal growth (optical density at 620 nm [OD620] 35% lower
than that of the wild type [WT]) but altered bioﬁlm formation (A560 at least 1.5-fold
different from that of the WT) and were screened for a second round. Thirty-three out
of 53 mutants (29 and 24 in the ﬁrst and second experiments, respectively) showed
consistent signiﬁcant differences in bioﬁlm formation after the transformation of
genomic DNA into the NTHi 13/4 WT strain.
The transposon insertion site was successfully identiﬁed for 30 transposon mutants
(Table 1). For the transposon mutants with at least a 2-fold decrease in bioﬁlm
formation (R2866 gene loci R2866_1635 [mltC] and R2866_1770 [lppB]) or 2-fold
increased bioﬁlm formation (R2866 gene loci R2866_0135 [ponA], R2866_0223 [ampG],
R2866_0638 [amiB], R2866_0673 [mrdA], R2866_1548 [dsbA], and R2866_1640), directed
gene deletion mutants of NTHi strain R2866, whose genome has been sequenced, were
constructed.
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The growth of the R2866ΔamiB, R2866ΔmrdA, R2866ΔampG, R2866ΔmltC, and
R2866ΔlppB bioﬁlm mutants was signiﬁcantly affected compared to that of WT R2866,
although the differences were small (see Fig. S1A in the supplemental material). The
deletions in R2866ΔampG, R2866ΔamiB, and R2866ΔmrdA increased bioﬁlm formation,
whereas the deletions in R2866ΔmltC and R2866ΔlppB resulted in decreased bioﬁlm
formation (see Fig. S1B). The R2866ΔmltC and R2866ΔlppB mutants were able to form
bioﬁlm mass, but the bioﬁlm was dislodged during washing, indicating that the
adhesion of these mutants was affected.
Phase-contrast microscopic analysis of bacterial morphology showed that the
R2866ΔamiB and R2866ΔmrdA mutants have an altered shape compared to that of WT
R2866. The R2866ΔmltC mutant was longer and the R2866ΔlppB mutant formed very
long chains compared to WT R2866, suggesting a defect in cell division (see Fig. S2).
Interestingly, mutations in R2866ΔponA, R2866ΔampG, R2866ΔamiB, and R2866ΔmrdA
were involved in peptidoglycan synthesis and recycling for Gram-negative bacteria (20).
Therefore, we further focused on these mutants, with R2866ΔampG as a model because
it showed the most prominent increase in bioﬁlm formation.
R2866ampG mutant bioﬁlm formation, adhesion, and aggregation. The
growth of the R2866ΔampG mutant, determined by measuring the OD620 of an
overnight culture, was signiﬁcantly decreased compared to that of WT R2866 (Fig. 1A).
In contrast, bioﬁlm formation, as determined by measuring crystal violet bioﬁlm
staining, was increased more than 2-fold (Fig. 1B). The slight decrease in growth was
likely due to a lower number of live bacteria because CFU counts in the medium were
signiﬁcantly lower (Fig. 1C), but this was not the case for CFU counts in the bioﬁlm
(Fig. 1D). This indicated that even though bioﬁlm formation was increased, no increased
bacterial CFU count was detected in the bioﬁlm; however, we cannot exclude the
formation of aggregates of multiple bacteria.
Adhesion is an essential ﬁrst step in bioﬁlm formation. The speed of initial adhesion
to a solid surface was determined by the bioﬁlm ring test after 2 and 4 h of static
growth at 37°C. Both the R2866ΔampG mutant and WT R2866 showed no differences
in the level of initial adhesion in vitro (Fig. 1E) or in adhesion to respiratory epithelial cell
line A549 (Fig. 1F). Bacterial aggregation can contribute to bioﬁlm formation, but this
was not signiﬁcantly different between the R2866ΔampG mutant and WT R2866
(Fig. 1G). Altogether, initial adhesion and aggregation were similar for the R2866ΔampG
mutant and WT R2866, whereas bioﬁlm formation and the presence of genomic DNA
in the bioﬁlm were increased.
TABLE 1 Transposon mutants with increased or decreased bioﬁlm formation
R2866 gene
locus
Gene
name Product
No. of
mutants
% of WT bioﬁlm
formation
R2866_1548 dsbA Thiol:disulﬁde interchange protein 3 332
R2866_0223 ampG Peptidoglycan permease AmpG 3 307
R2866_0673 mrdA Penicillin-binding protein 2 5 293
R2866_0135 ponA Penicillin-binding protein 1A 3 279
R2866_0638 amiB N-Acetylmuramoyl-L-alanine amidase 1 230
R2866_1640 Hypothetical protein 1 222
R2866_1798 xerC Site-speciﬁc tyrosine recombinase 1 196
R2866_0262 xerD Site-speciﬁc, tyrosine recombinase 1 179
R2866_1089 hprA Glycerate dehydrogenase 1 176
R2866_0781 moaC Molybdenum cofactor biosynthesis 1 166
R2866_1057 potC Spermidine/putrescine ABC transporter,
permease protein
1 163
R2866_0799 lppC Lipoprotein C 1 142
R2866_1209 gcvA Probable transcription activator 1 62
R2866_1826 rep ATP-dependent DNA helicase 1 62
R2866_0451 dnaQ DNA polymerase III, epsilon subunit 1 55
R2866_0833 maeB NADP-dependent malic enzyme 1 51
R2866_1635 mltC Membrane-bound lytic murein
transglycosylase C
1 44
R2866_1770 lppB Outer membrane antigenic lipoprotein B 3 7
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January/February 2017 Volume 2 Issue 1 e00329-16 msphere.asm.org 3
 o
n
 M
ay 15, 2017 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
Visualization of R2866ampG mutant bioﬁlm. The bioﬁlms formed by the WT
R2866 and R2866ΔampG mutant strains were visualized after 18 h of growth by crystal
violet staining to determine whether any morphological differences between the two
bioﬁlms were present. Whereas single bacteria were often visible in the WT bioﬁlm, the
bioﬁlm structure formed by the R2866ΔampG was more complex, with large dense
areas of crystal violet staining (Fig. 2A).
Confocal microscopy analysis of WT R2866 and the R2866ΔampG mutant revealed
that the bioﬁlm of the R2866ΔampG mutant was thicker, at almost 10 m, than the WT
R2866 bioﬁlm, which was 7 m thick (Fig. 2B).
Atomic force microscopy (AFM) visualization conﬁrmed that WT R2866 differed
strongly from the R2866ΔampGmutant in different features such as cell size, cell shape,
and the ability to produce bioﬁlm, as shown in Fig. 2C and Table 2. Topography images
are inﬂuenced by the bond order between the probe and the sample; in fact, it reﬂects
the shape of the surface. The error signal imaging is partially based on extra deﬂection
of the cantilever. Combination of the two images provides information about surfaces
and their properties. Moreover, roughness determination, a measurement of cell in-
tegrity, revealed differences in roughness between WT R2866 and the R2866ΔampG
mutant at 8 h, whereas they tended to converge at longer periods of incubation,
probably because of bacterial aging (Fig. 2D). After 12 and 24 h, differences in height,
length, and amplitude cannot be determined since the bacteria are embedded in large
amounts of extracellular matrix (Table 2).
Bacterial DNA contributes to increased bioﬁlm formation by the R2866ampG
mutant. Bioﬁlm formation requires initial bacterial adhesion, which is mainly depen-
FIG 1 Growth, adhesion, bioﬁlm formation, and aggregation of WT R2866 and the R2866ΔampG gene deletion mutant. (A)
Overnight growth determined by measuring OD620. (B) Bioﬁlm formation determined by measuring crystal violet light A560. (C,
D) Numbers of WT R2866 and R2866ΔampG gene deletion mutant CFU in medium (C) and bioﬁlm (D). (E) Initial adhesion to
a solid surface determined by the bioﬁlm ring test after 2 and 4 h of static growth at 37°C. The BFI was adjusted by the test
software and is inversely proportional to the number of adherent bacteria. (F) Percent adhesion of WT R2866 and R2866ΔampG
gene deletion mutant bacteria to A549 lung epithelial cells after 2 to 3 h of incubation. (G) Aggregation of WT R2866 and the
R2866ΔampG gene deletion mutant in 5 ml of sBHI medium as determined by OD620 after 0, 2, 4, and 8 h of static incubation.
An unpaired Student t test (A to F) or two-way analysis of variance with the Bonferroni post hoc test (G) was used for statistical
analysis (NS, not signiﬁcant; *, P  0.05; **, P  0.01; ***, P  0.001).
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dent on bacterial proteins and the presence of DNA, either bacterial or from the host
(15). The contributions of protein-mediated adhesion and DNA to bioﬁlm formation
were determined by adding proteinase K or DNase to the growth medium, respectively.
Adding proteinase K or DNase to the growth medium decreased bacterial growth as
measured by determining the OD620 of an overnight culture, but no differences
between WT R2866 and the R2866ΔampG mutant were observed (Fig. 3A). Proteinase
K treatment abrogated WT R2866 and R2866ΔampG mutant bioﬁlm formation com-
pletely (Fig. 3B), indicating that protein-mediated adhesion is required. DNase treat-
ment decreased R2866ΔampG mutant bioﬁlm growth to the level of WT R2866,
indicating that increased bioﬁlm formation by the R2866ΔampG mutant was depen-
dent on extracellular genomic DNA (Fig. 3B).
Next, we measured the genomic DNA copy number in the bioﬁlm by quantitative
PCR (qPCR) and found a signiﬁcantly greater DNA abundance in the R2866ΔampG
mutant bioﬁlm than in the WT R2866 bioﬁlm (Fig. 3C).
The R2866ampG mutant is more sensitive to bacterial lysis during static
growth. The static growth of WT R2866 and that of the R2866ΔampG mutant were
similar up to 5 h, but at later time points, the growth of the R2866ΔampG mutant
FIG 2 Microscopy analysis of WT R2866 and R2866ΔampG gene deletion mutant bioﬁlms. (A) WT R2866 and R2866ΔampG
gene deletion mutant bioﬁlms stained with crystal violet and analyzed by light microscopy. (B) WT R2866 and R2866ΔampG
gene deletion mutant bioﬁlms stained with SYTO 17 and analyzed by confocal microscopy. (C) Topography and error signals
of WT R2866 and R2866ΔampG gene deletion mutant bioﬁlms determined by AFM. (D) Average roughness of WT R2866 and
R2866ΔampG in the bioﬁlms calculated from topography images. An unpaired Student t test was used for statistical analysis
(***, P  0.001).
TABLE 2 Cell size analysis by AFM
Time (h)
WT R2866 R2866ampG
Ra (nm) Ht (nm)
Amplitude
(nm) Length (nm) Ra (nm) Ht (nm)
Amplitude
(nm) Length (nm)
8 2.63  0.95 29.13  7.33 670.2  60.3 1,221.1  181.0 12.47  5.05 181.8  86.7 733.2  87.8 1,030.2  208.4
12 8.25  3.14 NDa ND ND 11.36  4.59 ND ND ND
24 8.17  3.36 ND ND ND 10.92  4.35 ND ND ND
aND, not determined.
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stayed behind (see Fig. S3A), which was also observed in CFU counts (see Fig. S3B).
When fold increases in OD620 and CFU counts were calculated, the growth of WT R2866
was the same by both measurements (see Fig. S3C), whereas the CFU counts of the
R2866ΔampGmutant decreased compared to its OD620 (see Fig. S3D). These data might
indicate that there was more bacterial lysis of the R2866ΔampGmutant, contributing to
an increase in OD620 but not in viable bacterial cell counts.
To measure sensitivity to bacterial lysis, we cultured WT R2866 and the R2866ΔampG
mutant with Triton X-100, which weakens the membrane. The growth of WT R2866 was
decreased by 1 to 5% Triton X-100; however, this difference was even greater in the
R2866ΔampG mutant (Fig. 4A). Increased sensitivity to Triton X-100 was also observed
in other peptidoglycan synthesis-related mutants (R2866ΔamiB, R2866ΔmrdA), indicat-
ing that tampering with peptidoglycan biosynthesis increased sensitivity to Triton
X-100 (Fig. 4B).
-Lactam antibiotic interference with peptidoglycan synthesis increases WT
R2866 bioﬁlm formation. Previously, it was shown that subinhibitory concentrations
of -lactam antibiotics increased bioﬁlm formation by NTHi (11). Since -lactam anti-
biotics, like the gene deletions in our R2866ΔampG, R2866ΔamiB, and R2866ΔmrdA
mutants, also interfere with peptidoglycan synthesis, we determined the effect of
FIG 3 DNase and proteinase K treatment of WT R2866 and R2866ΔampG gene deletion mutant bioﬁlms. (A) Overnight growth
determined by measuring OD620. (B) Bioﬁlm formation by WT R2866 and the R2866ΔampG gene deletion mutant determined
by measuring crystal violet light A560 in the presence of proteinase K (100 g/ml) or DNase (100 g/ml). (C) Relative DNA
abundance in the R2866ΔampG gene deletion mutant compared to that in WT R2866 determined by qPCR detection of the
Haemophilus protein D gene (hpd). One-way analysis of variance with Tukey’s multiple-comparison test was used for statistical
analysis (NS, not signiﬁcant; *, P  0.05; **, P  0.01; ***, P  0.001).
FIG 4 Relative growth of WT R2866 and the R2866ΔampG gene deletion mutant with Triton X-100. (A,
B) Relative growth of WT R2866 and the R2866ΔampG gene deletion mutant (A) and other gene deletion
mutants (B) in sBHI with 1, 2.5, and 5% Triton X-100 compared to that in sBHI. Two-way analysis of
variance and the Bonferroni post hoc test (A) and one-way analysis of variance with Dunnett’s multiple-
comparison post hoc test (B) were used for statistical analyses (NS, not signiﬁcant; *, P 0.05; **, P 0.01;
***, P  0.001).
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cefuroxime on the bacterial growth, Triton X-100 sensitivity, and bioﬁlm formation of
WT R2866. The growth of WT R2866 was signiﬁcantly inhibited by 0.5 g/ml cefuroxime
and completely abrogated by 2 g/ml cefuroxime (Fig. 5A). Interestingly, sensitivity to
Triton X-100 was signiﬁcantly increased by 0.25 to 1 g/ml cefuroxime, indicating that
these bacteria are more sensitive to bacterial lysis (Fig. 5B). But even more importantly,
although overnight growth was decreased (Fig. 5C), bioﬁlm formation signiﬁcantly
increased in the presence of 0.25 to 0.5 g/ml cefuroxime (Fig. 5D). Similar results were
obtained with other -lactam antibiotics (amoxicillin-clavulanic acid, ampicillin, and
penicillin G) but not with other classes of antibiotics (see Fig. S4). In accordance with
the data on the R2866ΔampG mutant, inhibition of peptidoglycan biosynthesis with
0.25 to 0.5 g/ml cefuroxime increased the relative DNA abundance in the bioﬁlm
almost 10-fold (Fig. 5E) and DNase decreased bioﬁlm formation to control levels
(Fig. 5F), indicating that extracellular DNA is required for increased bioﬁlm formation.
Next, we determined the effect of subinhibitory concentrations of the -lactam
antibiotic cefuroxime on bacterial growth and bioﬁlm formation in 16 clinical NTHi
isolates. Increased bioﬁlm formation by 13 of 16 clinical isolates tested with cefuroxime
was found (see Fig. S5), indicating that this is a broad phenotype. Consistent with the
confocal microscopy analysis of the R2866ΔampGmutant bioﬁlm, cefuroxime increased
the bioﬁlm thickness of NTHi strain R2866 (Fig. 6A). At these sublethal concentrations
of cefuroxime antibiotics, WT R2866 bacteria exhibited behavior quite similar to that of
R2866ΔampG mutants in bioﬁlm-forming activity, as determined by AFM after 8 h
(Fig. 6B and C).
DISCUSSION
Because the mechanisms that contribute to bioﬁlm formation by NTHi are not
completely understood (15), we aimed to identify genes required for NTHi bioﬁlm
formation. In this study, we screened 4,000 transposon mutants and evaluated their
growth and bioﬁlm formation in an in vitro static bioﬁlm assay. Among the genes
identiﬁed, mltC and lppB showed a signiﬁcantly lower level of bioﬁlm formation,
FIG 5 -Lactam antibiotics increase bacterial lysis, relative DNA content, and bioﬁlm formation. (A) Growth of WT R2866 with
cefuroxime was determined after 3 h. (B) Relative growth of WT R2866 after 3 h with cefuroxime in sBHI with 2.5% Triton X-100
compared to that in sBHI. (C, D) Overnight growth with cefuroxime determined by measuring OD620 (C) and level of bioﬁlm
formation with cefuroxime determined by measuring crystal violet light A560 (D). (E) Relative DNA abundance in bioﬁlm
determined by qPCR detection of the Haemophilus protein D gene (hpd). (F) Bioﬁlm formation by WT R2866 with and without
0.5 mg/ml cefuroxime with or without 100 g/ml DNase determined by measuring crystal violet light A560. One-way analysis
of variance with Dunnett’s multiple-comparison post hoc test (A to E) and two-way analysis of variance with the Bonferroni post
hoc test (F) were used for statistical analyses (NS, not signiﬁcant; *, P  0.05; **, P  0.01; ***, P  0.001).
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possibly because of their elongated morphology. Both the MltC and LppB proteins
contain lysostaphin-like metalloproteinase (LytM) domains, which are known to be
involved in the cell division process (21). The R2866ΔmltC and R2866ΔlppB mutants
revealed that these proteins play a crucial role in bacterial cell division, since both
presented an aberrant cell morphology. These results are corroborated by a recently
published study wherein deletion of mltC (envC) or lppB (nlpD) from NTHi strain 176
affected cell morphology (22). Decreased bioﬁlm formation by R2866ΔmltC and
R2866ΔlppB seemed to be due to decreased adhesion because the bioﬁlm mass formed
after overnight growth was dislodged easily during the washing steps in our bioﬁlm
staining procedure.
We identiﬁed multiple transposon mutants that showed greater bioﬁlm formation
than WT R2866. Among those genes, four (R2866ΔponA, R2866ΔampG, R2866ΔamiB,
and R2866ΔmrdA) were related to peptidoglycan synthesis or recycling. We showed
that interference with peptidoglycan synthesis or recycling by making directed gene
deletion mutants increased bacterial lysis in the bioﬁlm, supplying genomic DNA and
thereby increasing bioﬁlm mass. Interestingly, -lactam antibiotics also act by blocking
peptidoglycan synthesis; therefore, we tested the hypothesis that -lactam antibiotics
would also increase bacterial lysis and bioﬁlm formation. Indeed, similar to the ﬁndings
obtained with the directed gene mutants, -lactam antibiotics increased sensitivity to
Triton X-100 and bioﬁlm formation at subinhibitory concentrations. This was also
observed by Wu and coworkers, who showed that subinhibitory concentrations of
-lactam antibiotics increased bioﬁlm formation by a variety of NTHi strains, which may
be due to the upregulation of genes involved in glycogen production (11). We provide
evidence that subinhibitory concentrations of -lactam antibiotics increase bacterial
lysis, thereby releasing bacterial genomic DNA, which contributes to bioﬁlm formation
in vitro. Subinhibitory concentrations of -lactam antibiotics increased bioﬁlm forma-
tion for 13 of 16 clinical NTHi isolates tested (see Fig. S5). The exact reasons why bioﬁlm
FIG 6 Microscopy analysis of WT R2866 bioﬁlm grown with -lactam antibiotics. (A) WT R2866 was grown
overnight with or without 0.25 and 0.5 g/ml cefuroxime, stained with SYTO 17, and analyzed by confocal
microscopy. (B) Topography and error signals determined by AFM. (C) Average roughness of WT R2866 grown with
or without 0.25 and 0.5 g/ml cefuroxime in the bioﬁlm calculated from topography images. One-way analysis of
variance with Dunnett’s multiple-comparison post hoc test was used for statistical analysis (***, P  0.001).
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formation by three clinical NTHi isolates was not increased is not known. Two isolates
showed a low bioﬁlm formation level under the control condition; therefore, it is
possible that initial attachment was not sufﬁcient and thus no increase in bioﬁlm
formation could be observed. Overall, inhibition of peptidoglycan biosynthesis with
subinhibitory concentrations of -lactam antibiotics increased bioﬁlm formation in
distinct clinical NTHi isolates. These data are of particular importance because bioﬁlm
formation increases resistance to antibiotic treatment and clearance by the immune
system (11), making these infections more difﬁcult to treat.
In support of an important role for DNA in the extracellular matrix of H. inﬂuenzae
bioﬁlms, we show that DNase reduces bioﬁlm formation by the R2866ΔampG mutant,
as well as WT R2866 treated with cefuroxime, conﬁrming that extracellular DNA is
required for the observed increase in bioﬁlm formation. DNase is considered to be a
useful adjunct treatment in children with recurrent or chronic OM (23), and our data
support the detrimental effect on H. inﬂuenzae bioﬁlms. Previously, we have shown that
DNase treatment reduced S. pneumoniae bacterial loads in the middle ear in a mouse
model (24). In fact, a clinical trial is determining whether DNase administered to the
middle ears of children undergoing surgery for grommet insertion can resolve OM (25).
Our data, in accordance with other in vitro studies (24, 26, 27), suggest that DNase
treatment has potential as a therapeutic measure in the resolution of OM.
Altogether, we provide evidence that release of bacterial DNA through bacterial cell
lysis contributes to bioﬁlm formation in vitro and that interference with this could
contribute to the clearance of NTHi bioﬁlms.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The NTHi strains used in this study are listed in Table S1.
The mutant library was generated by using NTHi strain 13/4, a bioﬁlm-forming isolate from an oropha-
ryngeal swab collected from a healthy child (18). Directed gene deletion mutants were generated in NTHi
strain R2866 (28). NTHi was routinely grown with shaking at 37°C in brain heart infusion (BHI) broth
(Becton Dickinson) supplemented with 10 g/ml hemin (Sigma-Aldrich) and 2 g/ml -NAD (Merck)
(sBHI). Growth on plates was performed with sBHI agar at 37°C and 5% CO2. Triton X-100 (Sigma) or
cefuroxime (Calbiochem) was used to supplement sBHI at the concentrations mentioned in the ﬁgure
legends.
Generation of the NTHi 13/4 transposon mutant library. Genomic DNA was isolated from
mid-log-phase cultures with the Qiagen DNeasy Blood and Tissue kit (Qiagen). The NTHi 13/4 marinerT7-
MmeI transposon mutant library was generated as described previously for NTHi 86-028NP (29). The
mutants were taken from sBHI plates and directly used in bioﬁlm experiments.
Static bioﬁlm formation assay. Bioﬁlm formation was determined by static growth on 96-well
plates and crystal violet staining as previously described (19). Proteinase K (100 g/ml) or DNase
(100 g/ml) was added to sBHI at the start of the experiment.
To screen for bioﬁlm formation by mutants, single colonies were diluted in 150 l of sBHI and
incubated at 37°C in 5% CO2 for 24 h. These experiments were performed with 1,806 and 2,366 colonies,
and the data were combined, for a total of 4,172 colonies. In each tested plate, the bioﬁlm formation and
growth of 95 transposon mutants and the 13/4 parent strain were tested. Before bioﬁlm staining, the
OD620 was determined to assess bacterial growth and the culture supernatant was transferred to a new
96-well plate for mutant storage. Bioﬁlm was stained as described above, and mutants that showed
normal growth (deﬁned as an OD620 35% lower than that of the WT) but altered bioﬁlm formation
(deﬁned as an A560 at least 1.5-fold different from that of the WT) were selected and stored at 80°C in
15% glycerol. The selected mutants were subjected to a second round of bioﬁlm formation to corrob-
orate phenotype differences. Because of the high number of false-positive transposon mutants in the ﬁrst
round, we performed a third round. In the third round, genomic DNA was isolated from each of the
selected mutants with the Qiagen DNeasy Blood and Tissue kit (Qiagen) and crossed back into WT 13/4.
At this point, the phenotypic modiﬁcations in these mutants were tested by performing a third round of
bioﬁlm formation.
Identiﬁcation of transposon insertions. Transposon insertion was identiﬁed by single-primer PCR.
One nanogram of genomic DNA was mixed with Taq PCR buffer, 2.5 mM MgCl2, 5 l of a 250 M
deoxynucleoside triphosphate mixture, 20 M primer (see Table S2), and 1 U of Taq DNA polymerase
(total volume of 50 l), and a PCR was run with the following program. Round 1 consisted of 30 s at 90°C,
30 s at 60°C, and 2 min at 72°C (30 cycles); round 2 consisted of 30 s at 90°C, 30 s at 30°C, and 2 min at
72°C (10 cycles); and round 3 consisted of 30 s at 90°C, 30 s at 55°C, and 2 min at 72°C (30 cycles),
followed by 5 min at 72°C. The PCR product was puriﬁed with the Qiagen PCR puriﬁcation kit (Qiagen).
A 100-ng sample of the PCR product was mixed with 5 pmol of sequence primer (see Table S2)
Generation of NTHi directed gene deletion mutants. Bacterial genomic DNA was isolated with the
Qiagen DNeasy Blood and Tissue kit (Qiagen). Directed NTHi gene deletion mutants were generated by
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allelic exchange of the target gene with a spectinomycin resistance cassette as described previously (29).
All of the primers (Biolegio) used in this study are listed in Table S2.
Phase-contrast microscopy. Bacteria grown in sBHI to an OD620 of 0.4 were centrifuged and washed
twice with phosphate-buffered saline (PBS). The ﬁnal bacterial pellet was completely resuspended in
100 l of PBS to remove all bacterial clumps and ﬁxed by adding 100 l of 4% paraformaldehyde. The
sample suspension was placed on a microscope slide and visualized with a Leitz Dialux 22 light
microscope with a Nikon Coolpix camera.
Confocal laser scanning microscopy. Overnight bacterial cultures were used to inoculate an
eight-well chambered cover glass for confocal image analysis (Ibidi GmbH) to a ﬁnal OD620 of 0.01 in 2 ml
of sBHI. The plates were incubated at 37°C for 24 h without shaking. After incubation, the wells were
washed with distilled water and stained for 15 min in the dark with the cell-permeating ﬂuorescent dye
SYTO 17 Red Fluorescent Nucleic Acid Stain in accordance with the manufacturer’s instructions (Molec-
ular Probes).
Samples were washed three times to remove nonspeciﬁc staining, and ﬂuorescence was observed by
confocal laser microscopy. Images of the double-labeled sections were acquired with a Leica TCS-SL
ﬁlter-free spectral confocal laser scanning microscope (Leica Microsystems, Inc.) with a 488-nm argon
laser, 543- and 633-nm He/Ne lasers (Centres Cientíﬁcs i Tecnològics, Campus de Bellvitge, Universitat de
Barcelona, Barcelona, Spain), a 63 oil immersion objective (1.4 numerical aperture), and an image
resolution of 1,024 by 1,024 pixels. The images were acquired randomly from the cover glass surface and
analyzed with the Leica Confocal Software 2.5 (Leica Microsystems, Inc.).
Sample preparation for AFM. Bioﬁlms were grown on Thermanox circular coverslips placed in
24-well microtiter plates covered with BHI medium and incubated at 37°C for different times. Afterward,
the slides were washed three times in Milli-Q water and left to air dry for imaging.
AFM imaging. AFM measurements were performed in air with an XE-70 (Park Systems) at room
temperature in noncontact mode with an ACTA silicon cantilever (Applied Nanostructures) with a
nominal resonance frequency of 300 kHz and a nominal force constant of 37 N/m. Samples were grown
as previously described and air dried for imaging. Measurements began by scanning a random area of
30 by 30 m, which was gradually decreased until the bacterial surface could be observed in detail.
Topography, amplitude, and phase images measuring 7.5 by 7.5 m were recorded simultaneously. The
acquired data were converted into topography, amplitude, and phase images and analyzed with XEI
software (Park Systems). AFM imaging also allowed cell surface roughness measurement. A roughness
average (Ra), meaning the average distance from the roughness proﬁle to the center plane of the proﬁle,
was obtained from the acquired topography images.
qPCR detection of genomic NTHi DNA. Bioﬁlms were scraped from the plate and suspended in
100 l of PBS. One microliter of bioﬁlm product was used in a qPCR. qPCR detection of the Haemophilus
protein D gene (hpd) was performed with speciﬁc primers (see Table S2) in a 20-l reaction volume with
SYBR green PCR master mix (Bio-Rad) and a real-time PCR detection system (Bio-Rad).
Bacterial adhesion assay. The speed of initial bacterial adhesion was evaluated by the bioﬁlm ring
test on modiﬁed 96-well polystyrene plates obtained from BioFilm Control (St. Beauzire, France) as
previously described (13). Brieﬂy, bacterial suspensions were mixed with magnetic beads, incubated for
2 or 4 h at 37°C, and placed on a magnetic block. BioFilm Control software was used to obtain the bioﬁlm
formation index (BFI); values of 7 corresponded to a total lack of bacterial adherence, while values of
5 were associated with different degrees of bacterial adherence.
A549 cell adhesion assay. The human lung epithelial cell line A549 (ATCC CCL-185) was routinely
grown in Dulbecco modiﬁed Eagle medium (DMEM) with GlutaMAX-I and 10% fetal calf serum (FCS;
Invitrogen) at 37°C and 5% CO2. Two days prior to the adherence assay, 2  105 A549 cells per well were
seeded into a 24-well tissue culture plate, and after 1 day, the growth medium was refreshed. After 2 days
of culturing, a conﬂuent monolayer of approximately 1  106 cells/well was formed. Bacteria were
washed once in DMEM with GlutaMAX-I and 1% FCS (infection medium) and resuspended in the
infection medium to 1 107 CFU/ml. The A549 cells were washed twice with PBS and infected with 1 ml
of the bacteria (multiplicity of infection, 10 bacteria per cell), which were allowed to adhere to the cells
for 2 to 3 h at 37°C in a 5% CO2 environment. Nonadherent bacteria were removed by three washes with
PBS, after which 1 ml of 1% saponin (Sigma-Aldrich) in PBS was added to detach and lyse the A549 cells.
Bacterial counts were determined at the start (inoculum), after 2 to 3 h of adhesion (total number of
bacteria), and after lysis in saponin (number of bacteria that adhered to and invaded cells). The
percentage of bacteria that adhered to and invaded cells was calculated by dividing the number of
bacteria that adhered to and invaded cells by the total number of bacteria plus the number of bacteria
that adhered to and invaded cells.
Aggregation assay. NTHi was grown shaking at 37°C in sBHI to an OD620 of ~0.9. Subsequently, 2 ml
of culture was incubated without shaking at 37°C in 5-ml tubes. To determine sedimentation as a result
of aggregation, the OD620 of the upper part of the tube was determined at 0, 2, 4, and 8 h.
Statistical analyses. Statistical analyses were performed with GraphPad Prism version 5.03 for
Windows (GraphPad Software, Inc.). Differences were considered signiﬁcant at P  0.05. The speciﬁc
statistical tests that were used for the various experiments are speciﬁed in the ﬁgure legends.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00329-16.
FIG S1, TIF ﬁle, 0.5 MB.
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FIG S2, TIF ﬁle, 2.8 MB.
FIG S3, TIF ﬁle, 0.5 MB.
FIG S4, TIF ﬁle, 0.8 MB.
FIG S5, TIF ﬁle, 1.3 MB.
TABLE S1, DOCX ﬁle, 0.1 MB.
TABLE S2, DOCX ﬁle, 0.1 MB.
ACKNOWLEDGMENTS
M.V. is a member of the ENABLE (European Gram-Negative Antibacterial Engine)
consortium (IMI-ND4BB, http://www.imi.europa.eu/content/enable). We thank Benja-
min Torrejon-Escribano of the Centres Cientíﬁcs i Tecnològics, Campus de Bellvitge,
Universitat de Barcelona, Barcelona, Spain, for confocal microscopy.
S.M. was supported by a postdoctoral contract from the CIBER de Enfermedades
Respiratorias (Instituto de Salud Carlos III [ISCIII], Madrid, Spain), and C.P. was supported
by an FPU (Formación de Profesorado Universitario, Ministerio de Educación, Spain)
grant. This study was supported by CIBER de Enfermedades Respiratorias (CIBERES:
CB06/06/0037), run by the ISCIII (Madrid, Spain). The work with the bioﬁlm ring test was
performed in the framework of a collaboration with BioFilm Control.
REFERENCES
1. Poole J, Foster E, Chaloner K, Hunt J, Jennings MP, Bair T, Knudtson K,
Christensen E, Munson RS, Jr., Winokur PL, Apicella MA. 2013. Analysis of
nontypeable Haemophilus inﬂuenzae phase-variable genes during ex-
perimental human nasopharyngeal colonization. J Infect Dis 208:
720–727. https://doi.org/10.1093/infdis/jit240.
2. Brook I. 2011. Microbiology of sinusitis. Proc Am Thorac Soc 8:90–100.
https://doi.org/10.1513/pats.201006-038RN.
3. Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF.
2007. Airway bacterial concentrations and exacerbations of chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 176:356–361.
https://doi.org/10.1164/rccm.200703-417OC.
4. Stol K, Verhaegh SJ, Graamans K, Engel JA, Sturm PD, Melchers WJ, Meis
JF, Warris A, Hays JP, Hermans PW. 2013. Microbial proﬁling does not
differentiate between childhood recurrent acute otitis media and
chronic otitis media with effusion. Int J Pediatr Otorhinolaryngol 77:
488–493. https://doi.org/10.1016/j.ijporl.2012.12.016.
5. Post JC. 2001. Direct evidence of bacterial bioﬁlms in otitis media.
Laryngoscope 111:2083–2094. https://doi.org/10.1097/00005537
-200112000-00001.
6. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes
M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC,
Ehrlich GD, Kerschner JE. 2006. Direct detection of bacterial bioﬁlms on
the middle-ear mucosa of children with chronic otitis media. JAMA
296:202–211. https://doi.org/10.1001/jama.296.2.202.
7. Starner TD, Zhang N, Kim G, Apicella MA, McCray PB, Jr. 2006. Haemo-
philus inﬂuenzae forms bioﬁlms on airway epithelia: implications in
cystic ﬁbrosis. Am J Respir Crit Care Med 174:213–220. https://doi.org/
10.1164/rccm.200509-1459OC.
8. Marsh RL, Thornton RB, Smith-Vaughan HC, Richmond P, Pizzutto SJ,
Chang AB. 18 March 2014. Detection of bioﬁlm in bronchoalveolar
lavage from children with non-cystic ﬁbrosis bronchiectasis. Pediatr
Pulmonol https://doi.org/10.1002/ppul.23031.
9. Domenech M, Ramos-Sevillano E, García E, Moscoso M, Yuste J. 2013.
Bioﬁlm formation avoids complement immunity and phagocytosis of
Streptococcus pneumoniae. Infect Immun 81:2606–2615. https://
doi.org/10.1128/IAI.00491-13.
10. Jensen PØ, Givskov M, Bjarnsholt T, Moser C. 2010. The immune system
vs. Pseudomonas aeruginosa bioﬁlms. FEMS Immunol Med Microbiol
59:292–305. https://doi.org/10.1111/j.1574-695X.2010.00706.x.
11. Wu S, Li X, Gunawardana M, Maguire K, Guerrero-Given D, Schaudinn C,
Wang C, Baum MM, Webster P. 2014. Beta-lactam antibiotics stimulate
bioﬁlm formation in non-typeable Haemophilus inﬂuenzae by up-
regulating carbohydrate metabolism. PLoS One 9:e99204. https://
doi.org/10.1371/journal.pone.0099204.
12. Zhang L, Fritsch M, Hammond L, Landreville R, Slatculescu C, Colavita A,
Mah TF. 2013. Identiﬁcation of genes involved in Pseudomonas aerugi-
nosa bioﬁlm-speciﬁc resistance to antibiotics. PLoS One 8:e61625.
https://doi.org/10.1371/journal.pone.0061625.
13. Puig C, Domenech A, Garmendia J, Langereis JD, Mayer P, Calatayud L,
Liñares J, Ardanuy C, Marti S. 2014. Increased bioﬁlm formation by
nontypeable Haemophilus inﬂuenzae isolates from patients with inva-
sive disease or otitis media versus strains recovered from cases of
respiratory infections. Appl Environ Microbiol 80:7088–7095. https://
doi.org/10.1128/AEM.02544-14.
14. Hong W, Juneau RA, Pang B, Swords WE. 2009. Survival of bacterial
bioﬁlms within neutrophil extracellular traps promotes nontypeable
Haemophilus inﬂuenzae persistence in the chinchilla model for otitis
media. J Innate Immun 1:215–224. https://doi.org/10.1159/000205937.
15. Langereis JD, Hermans PW. 2013. Novel concepts in nontypeable Hae-
mophilus inﬂuenzae bioﬁlm formation. FEMS Microbiol Lett 346:81–89.
https://doi.org/10.1111/1574-6968.12203.
16. Jurcisek JA, Bakaletz LO. 2007. Bioﬁlms formed by nontypeable Haemo-
philus inﬂuenzae in vivo contain both double-stranded DNA and type IV
pilin protein. J Bacteriol 189:3868–3875. https://doi.org/10.1128/
JB.01935-06.
17. Goodman SD, Obergfell KP, Jurcisek JA, Novotny LA, Downey JS, Ayala
EA, Tjokro N, Li B, Justice SS, Bakaletz LO. 2011. Bioﬁlms can be dispersed
by focusing the immune system on a common family of bacterial
nucleoid-associated proteins. Mucosal Immunol 4:625–637. https://
doi.org/10.1038/mi.2011.27.
18. Puig C, Marti S, Fleites A, Trabazo R, Calatayud L, Liñares J, Ardanuy C.
2014. Oropharyngeal colonization by nontypeable Haemophilus inﬂu-
enzae among healthy children attending day care centers. Microb Drug
Resist 20:450–455. https://doi.org/10.1089/mdr.2013.0186.
19. Puig C, Marti S, Hermans PW, de Jonge MI, Ardanuy C, Liñares J,
Langereis JD. 2014. Incorporation of phosphorylcholine into the lipooli-
gosaccharide of nontypeable Haemophilus inﬂuenzae does not correlate
with the level of bioﬁlm formation in vitro. Infect Immun 82:1591–1599.
https://doi.org/10.1128/IAI.01445-13.
20. Park JT, Uehara T. 2008. How bacteria consume their own exoskeletons
(turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev
72:211–227, table of contents. https://doi.org/10.1128/MMBR.00027-07.
21. Uehara T, Dinh T, Bernhardt TG. 2009. LytM-domain factors are required for
daughter cell separation and rapid ampicillin-induced lysis in Escherichia
coli. J Bacteriol 191:5094–5107. https://doi.org/10.1128/JB.00505-09.
22. Ercoli G, Tani C, Pezzicoli A, Vacca I, Martinelli M, Pecetta S, Petracca R,
Rappuoli R, Pizza M, Norais N, Soriani M, Aricò B. 2015. LytM proteins
play a crucial role in cell separation, outer membrane composition, and
pathogenesis in nontypeable Haemophilus inﬂuenzae. mBio 6:e02575.
https://doi.org/10.1128/mBio.02575-14.
23. Thornton RB, Wiertsema SP, Kirkham LA, Rigby PJ, Vijayasekaran S,
Coates HL, Richmond PC. 2013. Neutrophil extracellular traps and bac-
Bacterial Lysis Contributes to NTHi Bioﬁlm Formation
January/February 2017 Volume 2 Issue 1 e00329-16 msphere.asm.org 11
 o
n
 M
ay 15, 2017 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
terial bioﬁlms in middle ear effusion of children with recurrent acute
otitis media—a potential treatment target. PLoS One 8:e53837. https://
doi.org/10.1371/journal.pone.0053837.
24. Short KR, von Köckritz-Blickwede M, Langereis JD, Chew KY, Job ER,
Armitage CW, Hatcher B, Fujihashi K, Reading PC, Hermans PW, Wijburg
OL, Diavatopoulos DA. 2014. Antibodies mediate formation of neutro-
phil extracellular traps in the middle ear and facilitate secondary pneu-
mococcal otitis media. Infect Immun 82:364–370. https://doi.org/
10.1128/IAI.01104-13.
25. Vaccine Trials Group. 2016. Dornase alfa. Vaccine Trials Group, West
Perth, Western Australia, Australia. http://vaccine.telethonkids.org.au/
clinical-trials/dornase-alfa.aspx. Accessed 29 October 2016.
26. Hall-Stoodley L, Nistico L, Sambanthamoorthy K, Dice B, Nguyen D, Mershon
WJ, Johnson C, Hu FZ, Stoodley P, Ehrlich GD, Post JC. 2008. Characterization
of bioﬁlmmatrix, degradation by DNase treatment and evidence of capsule
downregulation in Streptococcus pneumoniae clinical isolates. BMC Micro-
biol 8:173. https://doi.org/10.1186/1471-2180-8-173.
27. Jones EA, McGillivary G, Bakaletz LO. 2013. Extracellular DNA within a
nontypeable Haemophilus inﬂuenzae-induced bioﬁlm binds human
beta defensin-3 and reduces its antimicrobial activity. J Innate Immun
5:24–38.
28. Williams BJ, Morlin G, Valentine N, Smith AL. 2001. Serum resistance in
an invasive, nontypeable Haemophilus inﬂuenzae strain. Infect Immun
69:695–705. https://doi.org/10.1128/IAI.69.2.695-705.2001.
29. Langereis JD, Zomer A, Stunnenberg HG, Burghout P, Hermans PW.
2013. Nontypeable Haemophilus inﬂuenzae carbonic anhydrase is im-
portant for environmental and intracellular survival. J Bacteriol 195:
2737–2746. https://doi.org/10.1128/JB.01870-12.
Marti et al.
January/February 2017 Volume 2 Issue 1 e00329-16 msphere.asm.org 12
 o
n
 M
ay 15, 2017 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
